![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: LIN7C |
Gene summary for LIN7C |
![]() |
Gene information | Species | Human | Gene symbol | LIN7C | Gene ID | 55327 |
Gene name | lin-7 homolog C, crumbs cell polarity complex component | |
Gene Alias | LIN-7-C | |
Cytomap | 11p14.1 | |
Gene Type | protein-coding | GO ID | GO:0001505 | UniProtAcc | Q9NUP9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55327 | LIN7C | PTC06 | Human | Thyroid | PTC | 3.67e-23 | 3.65e-01 | 0.2057 |
55327 | LIN7C | PTC07 | Human | Thyroid | PTC | 5.64e-23 | 3.57e-01 | 0.2044 |
55327 | LIN7C | ATC09 | Human | Thyroid | ATC | 4.41e-03 | 2.35e-02 | 0.2871 |
55327 | LIN7C | ATC12 | Human | Thyroid | ATC | 1.39e-08 | 3.43e-02 | 0.34 |
55327 | LIN7C | ATC13 | Human | Thyroid | ATC | 4.32e-16 | 1.39e-01 | 0.34 |
55327 | LIN7C | ATC1 | Human | Thyroid | ATC | 9.75e-03 | 3.65e-02 | 0.2878 |
55327 | LIN7C | ATC2 | Human | Thyroid | ATC | 2.64e-13 | 9.82e-01 | 0.34 |
55327 | LIN7C | ATC3 | Human | Thyroid | ATC | 1.65e-06 | 2.22e-01 | 0.338 |
55327 | LIN7C | ATC4 | Human | Thyroid | ATC | 1.85e-11 | 9.78e-02 | 0.34 |
55327 | LIN7C | ATC5 | Human | Thyroid | ATC | 3.85e-19 | 1.73e-01 | 0.34 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1990778 | Colorectum | AD | protein localization to cell periphery | 129/3918 | 333/18723 | 5.51e-14 | 1.15e-11 | 129 |
GO:0007163 | Colorectum | AD | establishment or maintenance of cell polarity | 77/3918 | 218/18723 | 5.72e-07 | 2.08e-05 | 77 |
GO:0045197 | Colorectum | AD | establishment or maintenance of epithelial cell apical/basal polarity | 20/3918 | 44/18723 | 2.26e-04 | 2.94e-03 | 20 |
GO:0035088 | Colorectum | AD | establishment or maintenance of apical/basal cell polarity | 21/3918 | 49/18723 | 4.31e-04 | 4.82e-03 | 21 |
GO:0061245 | Colorectum | AD | establishment or maintenance of bipolar cell polarity | 21/3918 | 49/18723 | 4.31e-04 | 4.82e-03 | 21 |
GO:0006887 | Colorectum | AD | exocytosis | 96/3918 | 352/18723 | 2.48e-03 | 1.90e-02 | 96 |
GO:19907781 | Colorectum | SER | protein localization to cell periphery | 98/2897 | 333/18723 | 6.09e-11 | 9.57e-09 | 98 |
GO:00071631 | Colorectum | SER | establishment or maintenance of cell polarity | 60/2897 | 218/18723 | 3.45e-06 | 1.33e-04 | 60 |
GO:00451971 | Colorectum | SER | establishment or maintenance of epithelial cell apical/basal polarity | 16/2897 | 44/18723 | 5.64e-04 | 7.83e-03 | 16 |
GO:00350881 | Colorectum | SER | establishment or maintenance of apical/basal cell polarity | 17/2897 | 49/18723 | 7.17e-04 | 9.44e-03 | 17 |
GO:00612451 | Colorectum | SER | establishment or maintenance of bipolar cell polarity | 17/2897 | 49/18723 | 7.17e-04 | 9.44e-03 | 17 |
GO:00068871 | Colorectum | SER | exocytosis | 75/2897 | 352/18723 | 2.05e-03 | 2.03e-02 | 75 |
GO:0030011 | Colorectum | SER | maintenance of cell polarity | 8/2897 | 19/18723 | 4.95e-03 | 3.84e-02 | 8 |
GO:19907782 | Colorectum | MSS | protein localization to cell periphery | 120/3467 | 333/18723 | 2.02e-14 | 5.47e-12 | 120 |
GO:00071632 | Colorectum | MSS | establishment or maintenance of cell polarity | 72/3467 | 218/18723 | 1.90e-07 | 8.30e-06 | 72 |
GO:00451972 | Colorectum | MSS | establishment or maintenance of epithelial cell apical/basal polarity | 19/3467 | 44/18723 | 1.38e-04 | 2.06e-03 | 19 |
GO:00350882 | Colorectum | MSS | establishment or maintenance of apical/basal cell polarity | 20/3467 | 49/18723 | 2.36e-04 | 3.24e-03 | 20 |
GO:00612452 | Colorectum | MSS | establishment or maintenance of bipolar cell polarity | 20/3467 | 49/18723 | 2.36e-04 | 3.24e-03 | 20 |
GO:199077819 | Esophagus | ESCC | protein localization to cell periphery | 217/8552 | 333/18723 | 4.08e-13 | 1.88e-11 | 217 |
GO:000716320 | Esophagus | ESCC | establishment or maintenance of cell polarity | 143/8552 | 218/18723 | 2.05e-09 | 4.65e-08 | 143 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
LIN7C | SNV | Missense_Mutation | c.385N>C | p.Asp129His | p.D129H | Q9NUP9 | protein_coding | deleterious(0.02) | benign(0.151) | TCGA-EK-A2RN-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
LIN7C | SNV | Missense_Mutation | c.392N>G | p.His131Arg | p.H131R | Q9NUP9 | protein_coding | deleterious(0.03) | benign(0.148) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
LIN7C | SNV | Missense_Mutation | c.564N>T | p.Met188Ile | p.M188I | Q9NUP9 | protein_coding | tolerated(0.07) | benign(0.001) | TCGA-F4-6703-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
LIN7C | SNV | Missense_Mutation | novel | c.199N>T | p.Pro67Ser | p.P67S | Q9NUP9 | protein_coding | deleterious(0.01) | benign(0.297) | TCGA-AG-3726-01 | Colorectum | rectum adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
LIN7C | SNV | Missense_Mutation | novel | c.320T>G | p.Ile107Ser | p.I107S | Q9NUP9 | protein_coding | deleterious(0) | possibly_damaging(0.597) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
LIN7C | SNV | Missense_Mutation | c.280G>C | p.Val94Leu | p.V94L | Q9NUP9 | protein_coding | deleterious(0) | possibly_damaging(0.612) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
LIN7C | SNV | Missense_Mutation | novel | c.524N>T | p.Pro175Leu | p.P175L | Q9NUP9 | protein_coding | deleterious(0.04) | probably_damaging(1) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
LIN7C | SNV | Missense_Mutation | rs777986916 | c.232N>G | p.Thr78Ala | p.T78A | Q9NUP9 | protein_coding | deleterious(0.01) | probably_damaging(0.998) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
LIN7C | SNV | Missense_Mutation | rs539932524 | c.577N>T | p.Arg193Cys | p.R193C | Q9NUP9 | protein_coding | tolerated_low_confidence(0.05) | benign(0.028) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
LIN7C | SNV | Missense_Mutation | c.130N>C | p.Ser44Arg | p.S44R | Q9NUP9 | protein_coding | deleterious(0.01) | probably_damaging(1) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |